Primary Care Prescribing Committee (PCPC)
|
|
- Silas Wilkerson
- 5 years ago
- Views:
Transcription
1 Primary Care Prescribing Committee (PCPC) Minutes of the Primary Care Prescribing Committee held on: 20 th February Time: at CCG, Carisbrooke Room / Bembridge Room, Building A, The Apex, St Cross Business Park, Newport, Isle of Wight, PO30 5XW. PRESENT: Oommen John (OJ) (Chair) Caroline Allen Tracy Savage (TS) Beth Shaw (BS) Nick Puckett (NP) Paul Howard (PH) Annie Adams (AA) Daphne Williams (DW) Michelle Legg (ML) Pauline Mairs (PM) Fran Alverez (FA) Debbie Cumming (DC) Matthew Leek (MaL) MINUTED BY: Chantal Cave (Medicines Optimisation Team Administrator) (CC) Item number as per agenda Item Title / Heading 1. Apologies / Introductions Liz Harrison (LH), Marie Locke (ML) Kieron Cooney (KC), Adam Poole (AP), Himanka Rana (HR) 2. Declarations of Interest Tracy Savage, Oommen John, Michelle Legg, Beth Shaw and Paul Howard. 3. Minutes of last meeting were agreed as a true record. Action 4. Outstanding Actions Introductory meeting to be arranged to discuss a Joint Formulary. To include Adrian Green (Chairman of Drugs Advisory Committee), Gill Honeywell (Chief Pharmacist at IOW NHS Trust) OJ and TS. Update: Agenda item 7- Formulary Update. MOT 5. Matters Arising Compilation of Shared Care Agreements (S) from mainland hospitals BS BS explained that the Shared Care Agreement database for regional Ss has been collated. The MOT will look at discrepancies between agreements and develop guidance. BS encouraged PCPC members to report requests for external shared care agreements to the CCG Shared Care inbox (sca@iow.nhs.uk) and BS is working on a policy statement for GPs. The PCPC members concluded that there has been a lack of communication and that more integrated working is essential. OJ would like to highlight that Dermatology have sent red drugs on Ss. BS will follow this issue up with LH. Page 1
2 Discharge Summaries FA FA explained an ongoing issue of community pharmacies no longer receiving faxes of discharge summaries. ML supports pharmacists receiving discharge summaries but would like assurance that the process is robust and streamlined. TS explained the proposed electronic notification of discharge that will be sent to pharmacies. The MOTIVE service becomes effective from 9 th April to enable pharmacists to provide targeted Medicine Use Reviews (MURs) or New Medicine Service (NMS). A launch event will take place in early March with information disseminated to GPs in the March edition of the MOT Newsletter. Liothyronine and Armour Thyroid TS TS introduced the SHIP8 CCG Priorities Committee draft policy recommendation on the use of liothyronine in the treatment of hypothyroidism and the CCG guidance on the prescribing of liothyronine (tri-iodothyronine, T3) and /or desiccated thyroid or thyroid extract products. TS clarified that Liothyronine should not be prescribed unless the patient has been seen by an NHS Endocrinologist. explained that EPACT data identifies spending of 200,000 p/a on Liothyronine by the CCG. TS confirmed that the SHIP8 policy did not support the initiation of prescribing of Amour Thyroid. TS explained that Liothyronine prescribing will need to be audited on a case by case basis with guidance for practices and prescribing by private consultants monitored. explained in the NHS England Drugs of Limited Clinical Value (DoLCV), The British Thyroid Association states the Liothyronine can only be prescribed after Levothyroxine has failed and patients have had a carefully audited trial of 3 months duration. The SHIP8 policy will be presented at the CCG Clinical Executive meeting in March ACTION Dermatology Ss. BS to follow this issue up with LH. MOTIVE Launch event information included in March MOT Newsletter SHIP8 CCG Priorities Committee draft policy recommendation on the use of liothyronine to be presented at the March CCG Clinical Executive meeting. BS to check CCG position with LMC in regard to medicines initiated by private specialist being prescribed on FP10. BS TS BS 6. COPD GSK research projects. Presented by Nick Puckett (Organisation Development Manager, One Wight Health) NP NP explained that One Wight Health (OWH) has been working closely with Dr Himanka Rana and Vectasearch to assess the effectiveness of TRELEGY ELLIPTA relative to non-ellipta Multiple Inhaler Triple Therapies (MITT) for chronic Obstructive Pulmonary Disease (COPD) control within the usual clinical practice setting. The Intrepid study summary was distributed to the PCPC members. Page 2
3 NP proposes that OneWight Health will act as the pick site co-ordinator for 16 GP practices across the Isle of Wight. OWH will act as the administrator and contact patients to gauge interest on signing up to the study. Details will then be passed onto Dr Rana and Vectasearch will develop the project. NP clarified that no data will leave the practice except those with patient consent and that patient letters are sent via OWH on behalf of practice. NP explained that funding for the project is standard research funding and a memorandum of understanding has been drawn up between Vectasearch and OWH. NP explained that it has been presented at the Practice Manager s Forum, and expressions of interest will be followed up and individually written to. 7. Formulary Section I. Update II. Thickener Review BS Update; BS explained that the Formulary is continuing to be refined and updated. BS has received notification that the NET Formulary is in place to be accessed. BS explained that the Formulary will match SystmOne to ensure that the formulary is accurate. BS explained to the PCPC the benefits of the NET formulary; a web based system that is pre-populated with BNF chapters / live data /audit trails / can be linked to shared care agreements and the MOT website / an integrated traffic light system and can pivot primary and secondary prescribing. BS will investigate the different interfaces available. TS communicated an aim to organise a Task and Finish group to link with MOT pharmacists and Trust Pharmacists and a wider intention for an Area Medicines Optimisation Committee. TS proses that governance and processes will be developed under the newly formed Area Medicines Optimisation Committee and will enable joint working and collaboration with consultants. SALT Thickener Formulary Review; explained that on 1 st February 2018 the Medicines Optimisation Team held a SALT Thickener Formulary Review and Nestle Resource Thicken Up Clear was chosen as the preferred option. The product won overall on quality, safety and was competitively priced. confirmed that the formula is suitable for all patients and will be used across secondary and primary care. TS confirmed that an action plan is being developed to support care homes with the use of this product. BS confirmed that the formulary will be updated to reflect this on SystmOne and ScriptSwitch has been updated. Page 3
4 ACTION Information on Nestle Resource ThickenUp Clear to be included in the March 2018 edition of the MOT Newsletter. 8. Pain and Medicines Management strategies: I. Isle of Wight Palliative Care Symptom Guidelines II. Opioid Review Report - Lidocaine Patches - Just in Case III. Prescribing of (long term) drugs with potential for habituation by psychiatry. IV. Discussion re Strategy going forward for QPSS PH AP TS Isle of Wight Palliative Care Symptom Guidelines; PH presented the updated draft of Isle of Wight Palliative Care Symptom Control Guidelines, accompanying Consultation Log and Recommended Traffic Light Allocations for palliative medicines on the Isle of Wight to the members of PCPC. PH requested feedback from the PCPC with an aim to secure approval from PCPC on the proposed document. The Guidance is pending approval from the Earl Mountbatten Hospice Quality and Governance Committee and St Mary s Hospital NHS Trust Clinical Standards Committee. PH highlighted a post submission change to Lidocaine conversion. The PCPC commended and approved the guidance. PH will inform the MOT that the guidelines have been approved by the EMH and St Mary s Hospital Trust, upload the guidelines onto the Primary Care launch screen and seek to implement the guidelines on a SystmOne template. will send out an update in the MOT Newsletter. ML explained that an update can be distributed at the CCG Locality meetings. Opioid Review Report; presented the Opioid Action Plan and Report for the South Wight Locality. explained that herself and David France (MOT Pharmacist) worked alongside an individual practice, remotely reviewed their patients on SystmOne, provided prescriber education and drafted a letter for those patients who would need to be reviewed for clinical safety. explained that the practice has reported that patients are receptive to the discussions. Lidocaine Patches; explained that an audit of lidocaine 5% medicated plaster prescribing for inpatients at the Isle of Wight NHS Trust was conducted at the Trust by an interim pharmacist and reported to DAC. The audit quoted is over an 8 month period. During those 8 months 12 patients were admitted already using the patches in primary care. Of the 18 patients started on patches whilst in hospital over the 8 month period, Page 4
5 only 4 were discharged with a patch, 3 of whom as out of license use with a full supply for short term use, not to be continued by the GP. The remaining 1 was in license. It is expected that all off licence prescribing of Lidocaine 5% medicated plasters (with the exception of chronic neuropathic pain in an outpatient setting) will be accompanied by an Unlicensed and Off-Licence Liability Form The MOT will present an update in the March 2018 MOT newsletter and continue discussions with Gill Honeywell. Just in Case; explained that there has been a number of Just In Case medications being used in a care home setting and errors have been made. has proposed an audit will take place as part of the MOT Technician Check process. Prescribing of (long term) drugs with potential for habituation by psychiatry; AP sent apologies and the item will return to PCPC at a later date. Discussion re Strategy going forward for QPSS; TS explained that learning outcomes from the opioid review demonstrates that reducing opioid prescribing would be valuable piece of work to undertake. ML would welcome practice support and PH would welcome a consistent message. OJ concurred that Opioids are a high priority and it should form part of the QPSS 18/19. TS explained that Polypharmacy will remain on the QPSS and a focus on polypharmacy reviews for care homes informed by SI reviews. Guidelines around Anti-Coagulants, NOACS and a consideration of deprivation indexes may also feature. ACTION PH to update MOT on the approval of the Palliative Care Symptom Guidelines by the Earl Mountbatten Hospice Quality and Governance Committee and St Mary s Hospital NHS Trust Clinical Standards Committee. PH to include Palliative Care Symptom Guideline update in the MOT Newsletter and ML to distribute an update at the CCG Locality meetings. /ML Updated guidance on Lidocaine patch prescribing to be included in March MOT Newsletter TS to present a draft version of QPSS 18/19 at the March PCPC 9. Prescription Ordering Direct (POD) TS TS explained that Prescription Ordering Direct (POD) has been discussed as an alternative to managed repeats by community pharmacies. This will enable a centralised base for patients to order repeat prescriptions. TS explained that when the scheme was introduced to Coventry and Rugby CCG there was a greater Page 5
6 than 6% reduction in Primary Care costs overall. TS recognised that this would initially impact work load but it would benefit practices in the long-term by reducing work load and offer an enhanced clinical oversight of prescription ordering. PM highlighted the issue of redeployment of practice staff. The PCPC concluded that the idea has many benefits but would like further clarification of the scheme. 10. SIP Feeds I. Invest to save proposal II. Guideline development TS/ TS/ TS asked the members to review the Oral Nutritional Supplement (ONS) proposal and feedback to TS regarding any observations and concerns. ML commended the proposal. 11. Finance MaL MaL explained that budgets for 2018/19 are being considered with an aim for an update at the March PCPC meeting. MaL is working closing with TS regarding the financial element of the QPSS 2018/19. ACTION CC will distribute the December prescribing data to the prescribing leads once EPACT report data is available. CC 12. AOB: AA raised the concern that there has been an increase in outpatient discharge of the white sheet. OJ concluded that is an ongoing concern and will discuss further with TS. FA distributed his B12 policy to the members of the PCPC for information AA FA 13. Date of Next Meeting: Tuesday 20 th March at the Beech Grove Surgery, The Mall, Brading, PO36 ODE. Page 6
7 Members Dr Oommen John (Chair [OJ]) Tracy Savage AD Medicines Optimisation(Deputy Chair [TS]) Dr Michelle Legg, GP, Tower House (ML) Dr Kieron Cooney, GP, St Helens Medical Centre (KC) Dr Benjamin Browne, GP, East Cowes (BB) Annie Adams, South Wight Medical Practice (AA) Caroline Allen, Deputy Head, Medicines Optimisation () Beth Shaw, Clinical Pharmacist Advanced (BS) Matthew Leek, CCG Finance Manager (MaL) Francisco Alvarez, LPC Rep and Community Caroline Morris, Head of Primary Care & Corporate Business (CMo) Melanie Rogers, Director of Quality and Clinical Services (MR) Pauline Mairs, Commissioning Manager (PM) Adam Poole (AP), GP Argyll House Pembe Hassan-Hicks St Helens (PH-H) Rachel Howard Esplanade (RH) Cath Miskin Shanklin (CM) Gill Honeywell St Marys (GH) Paul Howard Consultant in Palliative Medicine (PH) Pharmacist (FA) Daphne Williams, Patient Representative (DW) Georgina Newnham, Community Hearth Failure Nurse (GN) Vicky Cooney, St Helens Medical Centre (VC) Hayley Jeneson (HJ) Locality Specialist Medicines Optimisation Team Annika Conroy Project Support (AC) For information Clinical Executive Committee Primary Care Operational Group Page 7
8 Primary Care Prescribing Committee (PCPC) Date of Action Description Meeting 20/02/2018 SHIP8 CCG Priorities Committee draft policy recommendation on the use of liothyronine to be presented at the February CCG Clinical Executive meeting. 20/02/2018 Information on Nestle Resource ThickenUp Clear and Lidocaine patch prescribing to be included in the March edition of the MOT Newsletter. 20/02/2018 BS to check CCG position with LMC in regard to medicines initiated by private specialist being prescribed on FP10. Date Action Made Responsibility Updates Status 20/02/18 TS Paper prepared and presented at Clinical Executive meeting Thursday 15/03/18 Completed 20/02/2018 Included in the MOT newsletter - distributed to general practices and pharmacies 12/03/18. Completed 20/02/2018 BS Action 20/02/2018 MOTIVE Launch event information to be included in March edition of MOT Newsletter 20/02/2018 PH to update MOT on the approval of the Palliative Care Symptom Guidelines by the Earl Mountbatten Hospice Quality and Governance Committee and St Mary s Hospital NHS Trust Clinical Standards Committee. 20/02/2018 to include Palliative Care Symptom Guideline update in the MOT Newsletter and ML to distribute an update at the CCG Locality meetings 20/02/2018 Included in the MOT newsletter - distributed to general practices and pharmacies 12/03/18. Event took place on 07/07/18 20/02/2018 PH 20/02/2018 /ML Included in the MOT newsletter - distributed to general practices and pharmacies 12/03/18. Completed Action Completed 20/02/2018 TS to present an outline of QPSS 18/19 at the March PCPC 20/02/2018 TS Action Page 8
NHS ISLE OF WIGHT CLINICAL COMMISSIONING GROUP
NHS ISLE OF WIGHT CLINICAL COMMISSIONING GROUP High Cost Drug Policy 1 P age AUTHOR/ APPROVAL DETAILS Document Author Written By: Authorised Signature Authorised By: Helen Shields Tracy Savage and Beth
More informationCCG Annual General Meeting (AGM) AGENDA Thursday 19 July 2018, 17:30hrs to 19:00hrs
CCG Annual General Meeting (AGM) AGENDA Thursday 19 July 2018, 17:30hrs to 19:00hrs Riverside Centre, The Quay, Newport, Isle of Wight, PO30 2QR Item Item Title/Heading Initial Paper No /Attachment 1.
More informationPrescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services
Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationReducing medicines waste in Care Settings.
Reducing medicines waste in Care Settings. Good practice Guidance Recommendations for care home staff, prescribers and pharmacists working with care homes. This good practice guidance has been developed
More informationPrimary Care Strategy. Draft for Consultation November 2016
Primary Care Strategy Draft for Consultation November 2016 1 Introduction Welcome to the Isle of Wight CCG s draft Primary Care Strategy. The CCG is required to develop and publish a strategy that sets
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationNHS community pharmacy advanced services Briefing for GP practices
NHS community pharmacy advanced services Briefing for GP practices August 2013 This document has been developed jointly by NHS Employers, the Pharmaceutical Services Negotiating Committee (PSNC) and the
More informationVenue: Salford St James House Present: Name Designation Organisation CCG members
GREATER MANCHESTER MEDICINES MANAGEMENT GROUP Minutes Date: Thursday 16 th February 2017 Time: 1pm 3pm Venue: Salford St James House Present: Name Designation Organisation CCG members Dr Helen Burgess
More informationMethods: Commissioning through Evaluation
Methods: Commissioning through Evaluation NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning Strategy
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Final - Terms of Reference - Final CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Quality Committee (known as the Committee in these terms of reference) for the purpose of:
More informationPrescribing and Administration of Medication Procedure
Prescribing and Administration of Medication Procedure Version: 3.3 Bodies consulted: - Approved by: PASC Date Approved: 1.4.16 Lead Manager Lead Director: Head of Child and Adolescent psychiatry Medical
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationNHS ISLE OF WIGHT CLINICAL COMMISSIONING GROUP CLINICAL FUNDING AUTHORISATION POLICY
NHS ISLE OF WIGHT CLINICAL COMMISSIONING GROUP CLINICAL FUNDING AUTHORISATION POLICY AUTHOR/ APPROVAL DETAILS & VERSION CONTROL Author Version Reason for Change Date Status IW CCG Acute V1 New policy Sept
More informationBest Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationMEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY
MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0
WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review
More informationGluten-Free Food on Prescription Consultation Survey Results
Gluten-Free Food on Prescription Consultation Survey Results Public Meeting November 22, 2016 Chair: Dr John Rivers, NHS Isle of Wight (IW) Clinical Commissioning Group (CCG) Panel Dr John Rivers, NHS
More informationMinutes 18 July 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager
Quality and Clinical Governance Committee Date Chair Minutes 18 July @ 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager Members Present Gareth
More informationAssociation of Pharmacy Technicians United Kingdom
Please find below APTUKs views to the proposals for change in Community Pharmacy as discussed at the Community Pharmacy in 2016/2017 and beyond stakeholder meeting on the 4 th February 2016 Introduction
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on
More informationItem Discussion Lead
Minutes of the Patient Reference Group of NHS Nottingham West Clinical Commissioning Group Thursday 4 February 2016, 6.15-8:30pm at Rumbletums Café, Kimberley Present: John Crouch Mark Russell Richard
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationHealthwatch Coventry Steering Group pre-meeting At: am on 28 March 2017 Held At: Queens Road Baptist Church Centre. Minutes
Healthwatch Coventry Steering Group pre-meeting At: 10.00 am on 28 March 2017 Held At: Queens Road Baptist Church Centre Minutes Attendees: John Mason (Chair), Carol Fawkes, David Spurgeon, Derek Rawle
More informationClinical Pharmacists in General Practice March 2018
Clinical Pharmacists in General Practice March 2018 1. Background Following a successful national pilot programme, the General Practice Forward View committed over 100million to support an extra 1,500
More informationMedicines optimisation in care homes
Medicines optimisation in care homes Programme overview March 2018 NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops.
More informationStandard Reporting Template
Standard Reporting Template NHS England (Wessex) 2014/15 Patient Participation Enhanced Service Reporting Template Practice Name: Practice Code: Shanklin Medical Centre J84010 Signed on behalf of practice:
More informationInformation shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
More informationSouth East London Area Prescribing Committee (APC) 9 October at Lower Marsh. Final minutes
South East London Area Prescribing Committee (APC) 9 October at Lower Marsh Final minutes 1. Welcome, Introductions and Apologies received. 2. Conflicts of Interest declarations The Chair requested any
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationIn Attendance: Arlene Sheppard (AMS) Note Taker WNCCG Sarah Haverson (SHv) Commissioning Support Officer WNCCG
Agenda Item: 17.62 DRAFT Minutes of West Norfolk Primary Care Commissioning Committee Part One (Quorate) Held on 26th May 2017 2pm Education Room, Town Hall, Saturday Market Place, Kings Lynn PE30 5DQ
More informationWhitby and the surrounding area
Frequently Asked Questions Whitby and the surrounding area 1. What is the Fit 4 the Future programme for Whitby? There are two aspects to the Whitby Fit 4 the Future programme: 1. Transformation of Community
More informationJOB DESCRIPTION LEAD PRACTICE BASED PHARMACIST. Designated GP Practice in Federation area
JOB DESCRIPTION JOB TITLE: LOCATION: ACCOUNTABLE TO: RESPONSIBLE TO: PROFESSIONALLY RESPONSIBLE TO: LEAD PRACTICE BASED PHARMACIST Designated GP Practice in Federation area Federation Chair Practice Prescribing
More informationJOB DESCRIPTION. Progressive: A learning organization, encouraging innovation and continuous improvement.
JOB DESCRIPTION Job Title: Medicines Management Support Assistant Pay Band: Band 3 Hours of Work: Responsible to: Accountable to: Base Point: Contract Type 37.5 hours per week Prescription Order Line Manager
More informationNon-Medical Prescriber Registration Policy
Non-Medical Prescriber Registration Policy REFERENCE NUMBER Non medical prescribing policy VERSION V1 APPROVING COMMITTEE & DATE Clinical Executive Committee 4.8.15 REVIEW DUE DATE August 2018 1 1. Introduction
More informationSouth Gloucestershire Clinical Commissioning Group Improving the Patient Experience Forum Meeting
South Gloucestershire Clinical Commissioning Group Improving the Patient Experience Forum Meeting Date: 8 th February 2017 Time: 10am-12:30pm Location: The Batch, Warmley, Bristol MINUTES IPEF members
More informationStandard Operating Procedure Discharge/Transfer of Patients from St John s Hospice In-Patient Unit
Standard Operating Procedure Discharge/Transfer of Patients from St John s Hospice In-Patient Unit DOCUMENT CONTROL: Version: 1.1 Ratified by: Quality Assurance Sub Committee Date ratified: 2 February
More informationClinical pharmacists in general practice links with community pharmacy
Introduction Pharmacists employed in the GP clinical pharmacist NHS England programme are encouraged to complete online activity recording. One of the activities records how they are working with community.
More informationNon Medical Prescribing Policy Register No: Status: Public
Non Medical Prescribing Policy Policy Register No: 07049 Status: Public Developed in response to: Department of Health Policies, Prescribing Guidance & Legislation Contributes to CQC Outcome: 9 Consulted
More informationNational Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CCRN Portal for the latest version. Version: 5.2 Status: Consultation in
More informationLinda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies
Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and
More informationNHS DORSET CLINICAL COMMISSIONING GROUP GENERAL MEDICAL AND SURGICAL CLINICAL COMMISSIONING PROGRAMME (CCP) 26 JUNE 2014
NHS DORSET CLINICAL COMMISSIONING GROUP GENERAL MEDICAL AND SURGICAL CLINICAL COMMISSIONING PROGRAMME (CCP) 26 JUNE 2014 A General Medical and Surgical CCP Meeting took place on Thursday 26 June 2014 at
More information1. Title of Paper: NHS Vale of York CCG Local Enhanced Services (LES) Review
Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING Meeting Date: 5 September 2013 Report Sponsor: Rachel Potts Chief Operating Officer Report Author: Melanie Cooper and
More informationUnlicensed Medicines Policy
Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention
More informationCCG Policy for Working with the Pharmaceutical Industry
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
More informationLincolnshire County Council Officers: Professor Derek Ward (Director of Public Health) and Sally Savage (Chief Commissioning Officer)
Agenda Item 5 1 LINCOLNSHIRE HEALTH AND WELLBEING BOARD PRESENT: COUNCILLOR MRS S WOOLLEY (CHAIRMAN) Lincolnshire County Council: Councillors C N Worth (Executive Councillor Culture and Emergency Services),
More informationCommunity Pharmacy in 2016/17 and beyond
Community Pharmacy in 2016/17 and beyond Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving that vision,
More informationPharmacists and GP surgeries
The Royal Pharmaceutical Society (RPS) believes that primary care patients should have the benefit of a pharmacist s clinical expertise similar to that currently experienced by patients in hospital Introduction
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference This Committee will report to NHS Halton CCG Governing Body on the development, improvement and monitoring of all areas of quality. This will include clinical effectiveness,
More informationDONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August NHS Doncaster CCG RDaSH FT Doncaster LPC
Present: DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August 2015 NHS Doncaster CCG RDaSH FT Doncaster LPC Dr Rumit Shah ( APC Chair) Mr Mark Randerson- Head of Medicines
More informationTo contact us please
Issue 13, June 2015 Newsletter for Care Home staff, General Practitioners and Community Pharmacists The Caring for Care Homes team produced The Medicines Management Checklist in 2010 to provide care homes
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationUnlicensed Medicines Policy Document
Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale
More informationSwitch protocol: Brands to generic equivalent
Switch protocol: Brands to generic equivalent Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by HaRD CCG for
More informationCoventry and Warwickshire PNA
Premises Details Contractor Code (ODS Code) Coventry and Warwickshire PNA Community Pharmacy Survey Name of contractor (i.e. name of individual, partnership or company owning the pharmacy business) If
More informationBest Practice Guidelines - BPG 9 Managing Medicines in Care Homes
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationMEETING REPORT Healthier Northamptonshire COLLABORATIVE CARE TEAM. NENE CCG Collaborative Care Team. Date of Meeting: 28/8/14 Time: 9.
MEETING REPORT Healthier Northamptonshire COLLABORATIVE CARE TEAM Meeting/Project Name: NENE CCG Collaborative Care Team Date of Meeting: 28/8/14 Time: 9.30-12 noon LPC Representative Chief Officer Location:
More informationPRIMARY CARE COMMISSIONING COMMITTEE
PRIMARY CARE COMMISSIONING COMMITTEE Date of Meeting 21 March 2018 Agenda Item No 3 Title Minutes of Previous Meeting Purpose of Paper To agree the minutes of the Primary Care Commissioning Committee meeting
More informationCCG authorisation: the role of medicines management
May 2012 The NHS medicines bill for 2010 was 12.9 billion, of which secondary care costs accounted for 32%. Prescribing inflation in 2010 ran at 4.8% and it is estimated that around 14% of total CCG budgets
More informationFARFIELD GROUP PRACTICE MINUTES OF THE PATIENTS COUNCIL MEETING Held on 2 nd August 2017
FARFIELD GROUP PRACTICE MINUTES OF THE PATIENTS COUNCIL MEETING Held on 2 nd August 2017 Present: Attendance sheet circulated. Attendance number: 10 Chair: Cheryl Lamb (Practice Manager) Apologies: Vicky
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationReview of Local Enhanced Services
Review of Local Enhanced Services 1. Background and context 1.1 CCGs are required to prepare for the phasing out of LESs by April 2014 by reviewing the existing LES portfolio and developing commissioning
More informationPharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02
Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02 V02 issued Issue 1 May 11 Issue 2 Dec 11 Planned review May
More informationNHS Rotherham CCG Medicines Management Team on behalf of NHS Rotherham CCG. Community Pharmacists in NHS Rotherham CCG
SERVICE LEVEL AGREEMENT TO ENABLE COMMUNITY PHARMACISTS IN NHS ROTHERHAM CLINICAL COMISSIONING GROUP TO SUPPLY TREATMENT AND ADVICE FOR MINOR AILMENTS PREPARED BY: NHS Rotherham CCG Medicines Management
More informationNPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing
NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix
More informationNORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY
PLEASE NOTE POLICY IS UNDER REVIEW NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY Target Audience Brief Description (max 50 words) Action Required Providers, Commissioners
More informationPGDs are permitted for use only by registered health professionals (see enclosed link for full list
NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred
More informationTitle: Replacement of the Commissioning Advisory Forum Agenda Item: 9
Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose
More informationNHSGGC Respiratory Managed Clinical Network Annual Report 2010/11 Executive Summary and Table of Contents
NHSGGC Respiratory Managed Clinical Network Annual Report 2010/11 Executive Summary and Table of Contents The full report is available on the Respiratory MCN Website www.nhsggc.org.uk/respmcn 1. Executive
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Strategy for Non-Medical Prescribing Version No: 2.2 Effective From: 19 October 2016 Expiry Date: 19 October 2019 Date Ratified: 12 October 2016 Ratified
More informationOptimising Systems and Processes of Wound Care - A QIPP resource of good practice. Developing and Implementing a Wound Care Prescribing Policy
East & outh East England pecialist Pharmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety Optimising ystems and Processes of Wound Care - A QIPP resource of good
More informationDirectorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning Strategy Finance
NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning Strategy Finance Publications Gateway Reference: 06200
More informationImperial College Health Partners - at a glance
Imperial College Health Partners - at a glance Imperial College Health Partners - at a glance Our vision and purpose This document is intended to provide an introduction to Imperial College Health Partners
More informationNHS and LA Reforms Factsheet 5
NHS and LA Reforms Factsheet 5 Supply of medicines for public health commissioned services a factsheet for local authorities 1. Introduction As of April 2013, local authorities have responsibility for
More informationNational Cancer Action Team. National Cancer Peer Review Programme EVIDENCE GUIDE FOR: Colorectal MDT. Version 1
National Cancer Action Team National Cancer Peer Review Programme FOR: Version 1 Introduction This evidence guide has been formulated to assist Networks and their constituent teams in preparing for peer
More informationRBCH Actions to meet CQC Essential Standards
RBCH Actions to meet CQC Essential Standards REGULATION 17 How the regulation was not being met Patients, their relatives, and staff told us about incidents where people had not been treated with dignity
More informationStandard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services
Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services Reference No: Version: 1 Author: Emma Baggaley First Issued On: 1 st March 2018 Latest
More informationPrimary Care Co Commissioning Committee Minutes of Meeting held in Public on Wednesday 22 nd June
Primary Care Co Commissioning Committee Minutes of Meeting held in Public on Wednesday 22 nd June 2016 14.00-16.00 Boardroom, SRCCG Offices, Town Hall, Scarborough Chair: Andy Hudson Present Greg Black
More informationBest Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers
Medicines Management in Care Homes Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers 1. Communication The care home manager, community pharmacist and GP surgery should
More informationCollaborative Commissioning in NHS Tayside
Collaborative Commissioning in NHS Tayside 1 CONTEXT 1.1 National Context Delivering for Health was the Minister for Health and Community Care s response to A National Framework for Service Change in the
More informationMoving the Green Medicines Bag from the Safety Agenda to QIPP
Moving the Green Medicines Bag from the Safety Agenda to QIPP Jane Hough (ESEE Specialist Pharmacy Services) Fiona Eccleston (PSF Project Manager) Ed England ( Ambulance Service) Facts and figures 97%
More informationOne months notice of termination must be given if the pharmacy wishes to terminate the agreement before the given end date.
Service Level Agreement for a Local Service for the Provision of Domiciliary Medicine Use Reviews Please note that for this service will be commissioned for a limited number of patients initially 10 (TEN)
More informationCoastal West Sussex Interface Prescribing Policy
Coastal West Sussex Interface Prescribing Policy Agreement between Commissioners: Coastal West Sussex CCG And Providers: Western Sussex NHS Foundation Trust (WSfT) Sussex Community NHS Trust (SCT) Sussex
More informationClinical Executive Committee formal Meeting Thursday 05 October 2017, 9.30am-12.00pm Beccles House
item 24 Clinical Executive Committee formal Meeting Thursday 05 October 2017, 9.30am-12.00pm Beccles House Present Name: Position: Organisation: Dr Paul Berry (PB) Retained GP representing planned Careers
More informationProcedure to Allow Nursing Staff to Dispense Leave and Discharge Medication
Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication Version 2 minor update June 2013 Procedure Number Replaces Policy No. Ratifying Committee N/a PPPF Date Ratified April 2009 Minor
More informationAppendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH
Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH All prescribers and their managers/professional leads should ensure
More informationNotes of the High Weald Lewes Havens Operational Leadership Team meeting held on Wednesday 10 July 2013, Boardroom, Friars Walk, Lewes
Notes of the High Weald Lewes Havens Operational Leadership Team meeting held on Wednesday 10 July 2013, Boardroom, Friars Walk, Lewes Present: Dr Elizabeth Gill Clinical Chair of the Governing Body (EG)
More informationImplementing bulk prescribing for care home patients
Bulletin 66 May 2014 Community Interest Company Implementing bulk prescribing for care home patients There are many patients in care homes taking medicines when required (prn), and this inevitably presents
More informationProcedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG
Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG Introduction All health and social care organisations are accountable for ensuring the safe management of controlled drugs
More informationGuidance For Health Care Staff Within NHS Grampian On Working With The Pharmaceutical Industry And Suppliers Of Prescribable Health Care Products
Title: Identifier: Guidance For Health Care Staff Within NHS Grampian On Working With The Pharmaceutical Industry And Suppliers Of Prescribable Health Care Products NHSG/guid/PharmInd/GMMG/738 Replaces:
More informationCommunity Pharmacy Multi-compartment Compliance Aids Audit
Community Pharmacy Multi-compartment Compliance Aids Audit Introduction To comply with the NHS contractual requirements associated with the Clinical Governance Essential Service, pharmacy contractors must
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationAGENDA ITEM 01: Chairs Welcome and Apologies
NHS CUMBRIA CLINICAL COMMISSIONING GROUP MINUTES OF GOVERNING BODY MEETING Wednesday 2 December 2015, 13:00 The Masonic Hall, Jacktrees Road, Cleator Moor, Cumbria. CA25 5AU Present: Les Hanley Lay Member
More informationGP and Lead Clinician, Respiratory MCN (chair) Respiratory Care Facilitator, WL CHCP
LOTHIAN RESPIRATORY MCN CORE GROUP Minutes of the meeting of Tuesday, 14 May 2013, 2.00pm to 3.30pm, Seminar Room 3, Chancellor s Building, Royal Infirmary of Edinburgh Present Dr Ninian Hewitt Ms Shena
More informationNorth School of Pharmacy and Medicines Optimisation Strategic Plan
North School of Pharmacy and Medicines Optimisation Strategic Plan 2018-2021 Published 9 February 2018 Professor Christopher Cutts Pharmacy Dean christopher.cutts@hee.nhs.uk HEE North School of Pharmacy
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationMEDICINES RECONCILIATION GUIDELINE Document Reference
MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012
More informationOxfordshire Primary Care Commissioning Committee
Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 6 March 2018 Paper No: 6 Title of Paper: Prescribing Incentive Scheme 2018-19 Proposal Paper is
More informationPrescribing Quality Review Scheme (PQRS) 2016/17
Introduction: The Prescribing Quality Review Scheme (PQRS) has been designed to reflect the four key principles of medicines optimisation: Understanding and improving patient experience. Evidence based
More information